text:
In the modern era, it seems as though inclusivity is becoming more and more imperative to social success. Gays want to be accepted by the public, and they are. Trans-folk want to be accepted by the public, and they are. Mentally deficient/retarded/disabled/ill people want to be accepted, and they are. By and large, what was once seen as "weird" or taboo is now socially acceptable. That's not to say that discrimination doesn't happen, because it does. But generally, these groups are accepted into normal society.
Everyone likes to be accepted, right? Humans are social animals. We like communication, getting together for a common purpose, etc. From a psychological standpoint, it makes sense that all these groups want to be accepted by everyone else. However, the problem lies in how far they're willing to go in order to be accepted.
"If you don't accept me, you're a bigot!" We've all seen it, and we've all cringed at the sight. The word "bigot" has become the go-to insult for anyone who is faced with disagreement. Nowadays, bigotry is putting someone down for the beliefs, values, or opinions they hold. We've all called someone an idiot for something they think. It's not exclusive to anyone. Everyone does it. In my eyes, as long as you aren't planning to hurt anyone, who cares? Someone doesn't agree with your lifestyle and they don't want to associate with it? Oh, how terrible. People shouldn't and can't be forced to accept something they don't like. Sure, over time a tolerance will be developed, but that isn't acceptance.
As stated before, acceptance can't be forced. The problem with many LGBT rights groups, trans rights groups or any of the other groups, is that they are forcing it. They demand acceptance or you shall suffer the consequences(whatever they may be). Don't disagree with any of the statistics they use to further their agenda, even if they are wrong or misrepresented. If you do, you're a bigot and a jerk. Another issue I see, is that while they want to be accepted as "normal," they want their own special events? All these pride parades and similar events seem unnecessary, at least to me. It's just something that says, "HEY LOOK AT ME! I'M GAY! LOOK AT ME! YOU HAVE TO ACCEPT ME!" It's tacky, and serves no purpose other garnering large amounts of attention.
Even obese people demand acceptance of their unhealthy lifestyles. "Hey, I'm overweight/fat/obese because of [medical problem]." That's fine, but those aren't the people I'm talking about. It's the people like Tess Holliday, who are unhealthy purely due to laziness and improper diet. Being fat is unhealthy, that is the bottom line. Obesity can be linked to heart problems, breathing problems, diabetes, a plethora of other medical issues. Groups like the National Association to Advance Fat Acceptance (NAAFA) and the International Size Acceptance Association (ISAA) are part of this new wave of making obesity ok. The proponents of this movement claim that being fat isn't a problem in and of itself, and that in most cases, long term weight loss is unsuccessful. Being fat is a problem; that fact can't really be argued. Weight loss being unsuccessful is arguable, but only because it really depends on the individual and their desire to become and stay healthy. Being fat isn't beautiful, it's not cool, it's not sexy. It's a problem. And giving people like Tess Holliday the spotlight just exacerbates the problem. "Oh well you can still be healthy and be fat, it's about eating healthy." Many athletes are overweight, but due to the large amount of physical activity they participate in, their diet, and the low levels of unhealthy fat in their body, it's not an issue. If you're eating healthy, but you're still overweight/obese, and you aren't physically active, you aren't healthy.
Then we see all the taboo and just outright fake groups of people who are seeking widespread acceptance. The entire "-kin" thing, all the made-up genders, and pedophiles are all included. These are things that are not, and should never be acceptable in society. The fight for pedophile rights is already on the rise. Some folks are attempting to normalize pedophilia and promote its acceptance in society. It's disgusting and I can't even express how sickened I am by it.
The fact that this picture exists shows the level of degradation of social norms. This is okay, because it's "art." Menstrual blood on a canvas is okay because it's "art." It's expected that we are going to transform into some magical society that accepts everyone and everything, regardless of how jacked up or disgusting it is. And that, is how a culture collapses. You add bad ingredients into any stew, and that stew ends up tasting terrible.


text:
Welcome to Fonda Don Chon Restaurant we are a family owned and operated establishment. We focus on our New estilo Jalisco (Jalisco Mexican style) menu.
From family friendly trips with kid friendly activities to local plumbers lawyers, spas, and contractors. Judy's Book has millions of listings and reviews for the best and not so great. Whether you're looking for a specific business or just trying to discover great places we make it easy. We're a family oriented site focusing on bringing trusted reviews and recommendations to moms and others. Green and Sustainable places are becoming more relevant to Judy's Book users, have a favorite place? Write a review and tell users why it's Green!

subset: commoncrawl


text:
While Colorado is still firmly in the grips of fall weather, winter is headed to the Rocky Mountain region. With winter in Colorado comes heavy snow and that means Traction Laws can be put into effect.
Traction Laws in Colorado are codes put into enforcement during or just ahead of a severe winter storm that can affect driving conditions. Failure to follow these codes can result in a ticket and hefty fine if you subsequently slide off the road and need to be rescued or block traffic while stuck.
Colorado last activated the traction code in March of 2016 when a heavy blizzard shut down most of Denver. See below for the codes, what they mean for you, and what you need to do to prepare.
Traction Law (Code 15) — Use George's Head to Check Your Tread
• If weather conditions require, CDOT will implement a Traction Law.
• Under a Traction Law, motorists will need to have either snow tires, tires with the mud/snow (M+S) designation, or a four-wheel/all-wheel drive vehicle — all tires must have a minimum one-eighth inch tread.
Passenger Vehicle Chain Law (Code 16) — Chain Up or Stay Off
• During severe winter storms, CDOT will implement a Passenger Vehicle Chain Law — this is the final safety measure before the highway is closed.
• Under a Passenger Vehicle Chain Law, every vehicle on the roadway is required to have chains or an alternative traction device (like AutoSock).
• Motorists driving with inadequate equipment during a Traction Law or Passenger Vehicle Chain Law could be fined more than $130.
• If a motorist blocks the roadway because they have inadequate equipment during a Traction Law or Passenger Vehicle Chain Law, they could be fined more than $650.
Traffic Facts
• At 60 MPH on snowy pavement, winter tires require 310 ft. to stop. All-season tires require more than double that (668 ft.).
• In 2014, one of the worst traffic delays on the I-70 Mountain Corridor was caused by unprepared motorists. Severe delays were caused by 22 vehicles spinning out and causing crashes — 19 of those vehicles had worn tires.
• Traffic accidents — not volume — account for as much as 60 percent of all traffic delays.


text:
About Meeting Place
The meeting place is a place where young LGBTQ people aged 15-25, who have applied for asylum, or are new to Sweden, can meet. It is a place where the focus is on strengthening each other through different types of activities.
Meeting Place activities
The themes for Meeting Place are rights, safer spaces and creative processes. Sometimes we invite external guests and talk about rights, about the body or we may shift the focus for one evening and learn about how to make films, theater or write a poem.
We believe that using creativity makes you feel good. We also find a way of communicating with each other in the group through our common language of art.
There are always 2 to 3 youth leaders working at Meeting Place.
Meeting Place times and locations
Meeting Place is currently held in 2 locations in Sweden. The location of Meeting Place is sent to participants once the location has been confirmed.
- STOCKHOLM: Mondays, 5pm – 7pm
- LINKÖPING: Mondays, 3pm – 6pm
- Gothenburg: Tuesdays, 4pm – 8pm
Sign up for Meeting Place
If you have questions or are interesting in joining Meeting Place, fill in the form below.


text:
President Traian Basescu to be sworn in on Monday
There will follow the solemn meeting for the 20th anniversary of the Revolution. Traian Basescu was validated on December 16 by the Constitutional Court for the position of Head of State for the second five-year mandate.
Dignitaries, magistrates and politicians, among whom mentioned should be made of Emil Boc, Nicolae Vacaroiu, Vasile Blaga, Adriean Videanu, Laura Kovesi, Catalin Predoiu, Roberta Anastase, Puiu Hasotti, Lidia Barbulescu, Gheorghe Pogea, Hunor Kelemen, attended the ceremony.
On December 18 the rulings made by the Constitutional Court on validating the result of the presidential election were published in Romania's Official Gazette. On December 14 Romania's Constitutional Court validated the presidential election and found that Traian Basescu was elected President in the second round of voting on December 6, with 50.33 percent of the votes cast.
On December 11 the Constitutional Court ruled that the null votes cast in the runoff presidential election should be re-counted after the Social Democratic Party had filed an application for annulling the election on December 8. On December 14 the Constitutional Court ruled on rejecting the appeal filed by the Social Democratic Party.
On December 16, during the validation ceremony at Romania's Constitutional Court, President Traian Basescu said that his main aim was that every Romanian should feel that the President was his too, no matter for whom he voted in the runoff presidential election on December 6.
He also said that Romania was through a relatively difficult time, in the context of the crisis, and that, at this moment, one needed solidarity more then ever before. The President added that his main aim was the modernization of the state.
"We have a state that, by its costs, is a heavy burden on every Romanian's shoulders. We must simplify the state, we must make the resources spent on the functioning of the state turn into resources at the disposal of Romania's development," he said.
Basescu remarked that the responsibility of a President when fulfilling his second mandate was higher than the one he had for the first mandate, considering the experience he acquired. He added that the Head of State was duty bound to find the political formulas that should help him entirely or mostly carry out the programme with which he won the election. He also thanked the Constitutional Court and said that, by the decision on having the null votes re-counted, it consolidated the credibility of the election.


text:
We are a community-based, sessional and all day Early Childhood Kindergarten for children aged 2½ - 5 and their families. Our kindergarten is well resourced and offers small group sizes and excellent teacher-child ratios. We provide a friendly, dynamic and safe learning environment founded on Christian values and beliefs.
Contact Us:
Phone: 09 626 6655
Email: email@example.com
Address: 506 Blockhouse Bay Road, Blockhouse Bay, Auckland


text:
So tomorrow is the big day. And this is when any sane, reasonable citizen of the United States must hold his/her nose and vote for Hillary Clinton.
Having said that, it might surprise you, dear reader, to learn that Pendulum is not anti-Trump for the usual hackneyed, clichéd, overblown howls and moans that the outrage-mongers have been persistently feeding us.
No, my gripe with The Donald lies rather with the fact that he is mentally unfit to be President. He is an imbecile and a trigger-happy egomaniac who will be totally incapable of holding the most powerful office in the world.
Yet it cannot be denied that large parts of the American electorate, and indeed the world, have been outraged by many of the "racist," "xenophobic," "Islamophobic," and "___phobic," (add at will) remarks that Mr. Trump has made during his campaign. As such, it is useful to unpack some of his most controversial claims, and to address them directly:
1) His pledge to build a wall with Mexico to stop illegal immigrants from entering the US (with a "big, beautiful door" to allow for legal immigrants).
Especially among many elements on the political left, it would seem, curiously, as if controlling who enters one's own nation is totally offensive and unacceptable concept. One wonders why these people who are howling and moaning about this particular policy even bother to have doors and locks in their homes.
They would probably respond that this analogy is, "not exactly comparing the exact same thing"… or something like that. As if analogies ever are. But I think it is sufficiently comparable to capture the jist of the issue; that is to say, that we like to be in control, rightly, of who is allowed to enter our own territory. And it is my that there is nothing inherently wrong in doing this, especially if millions of people have been entering our territory illegally in recent decades.
2) His claim that illegal Mexican immigrants are, "bringing drugs," "bringing crime," and that, "they are rapists." He attempted to mollify this statement by adding the caveat that, "some, I assume, are good people."
This statement, although crass and totally lacking in intellectual sophistication, has been completely blown out of proportion. Mr. Trump has been called a "racist" against all Mexicans, even though he was clearly only discussing illegal immigrants from Mexico. Incidentally, is "Mexican," even a race?
Peter Thiel, the billionaire investor and trump supporter, has made the erudite observation that Trump supporters have taken Mr. Trump "seriously, but not literally," while the media has taken Trump, "literally, but not seriously."
And this precisely captures the problem with people who call Trump a "racist," against all Mexicans. Of course he isn't. He just meant to make the point that illegal immigrants might have a higher rate of criminality than do legal, vetted immigrants.
3) His plan to stop Muslims, "entering the United States" … "until our country's representatives can figure out what the hell is going on." This, he later clarified in a recent debate, has evolved into a policy of, "extreme vetting."
This policy was presented as proof of Mr. Trump's "Islamophobia." But there is, I would argue, nothing "Islamophobic," about banning groups of people within which there will almost certainly be a minority of people willing to do us harm, or whose second generation children may want to do us harm in the future.
In other words, nobody, including Mr. Trump, is saying that all Muslims are bad, or that Islam is inherently bad. Rather, that there exists a small minority, albeit a deeply problematic and lethal one, within Muslim communities across the West, and that perhaps it is better for America to temporarily suspend Muslim immigration while we figure out how to better integrate those who are already here.
4) His pledge to appoint pro-life Supreme Court Judges.
Although no doubt this would be a great setback for women, it is worth remembering that virtually every Republican in Congress is pro-life. Indeed, being pro-life is almost a litmus test for one's fitness to be a member of the Republican Party.
The Pendulum view on this issue is that although it is very important to support a woman's right to choose, this topic is not #1 on my list of priorities for choosing a Presidential candidate. In other words, if, for example, one had to choose between two candidates, one who is pro-life and the other who is pro-choice, one should opt for the candidate with a better set of national security and economic policies, rather than reflexively choose the pro-choice candidate. Because, you know, nobody is getting an abortion if we are all dead or impoverished.
No, dear reader, it is none of the above policy proposals that should deeply trouble us. In fact, some of them, despite Mr. Trump's crude and unsophisticated elocutions, might actually be rather sensible.
However, let me be unequivocal in my assertion that under no circumstances is Mr. Trump fit to be President of the United States of America.
The issue rather has to do with Mr. Trump's temperament, and for lack of a better word, his idiocy. He is a fool, pure and simple, albeit one who has an unparalleled knack for connecting with the ordinary voter.
This is a man who probably couldn't tell us what the capital of Portugal is, or at what temperature water boils. I am willing to bet that he has not even read a single book in the past twenty years of his life. Would he respect diplomatic protocol on the global stage? Don't hold your breath.
This is a man who very crudely and vengefully went after Fox News reporter Megyn Kelly for (not unjustifiably) questioning his attitudes towards the female sex. This is a man who called Rosie O'Donnell a "slob," who talks like a, "truck driver." He mocked the physical appearance of Ted Cruz's wife, and slapped all sorts of asinine nicknames upon anyone who stood in his way ("Low energy Jeb"; "Lyin' Ted"; "Little Marco"; "Elizabeth Warren AKA Pocahontas"; and of course "Crooked Hillary").
Such puerile, vindictive tactics have been par for the course throughout Mr. Trump's life, be it personal or professional. He has bullied, belittled, and steamrolled his way through anyone or anything that has ever stood in his path. He has called for libel laws to be made more robust in order to stave press criticism of himself. He has stated that a judge of Mexican descent was unfit to preside over his Trump University case. He has irresponsibly asked, "Second Amendment people," to make sure Hillary Clinton does not appoint liberal Supreme Court judges in the event of her victory.
Although I do not support the notion that Mr. Trump is a closet fascist, as some are overly keen to do, he is clearly of an unsound mental state to be President of the Free World.
Ergo, with all this being said, despite her immense faults and thoroughly noxious personality, it is it Mrs. Clinton for whom we must vote come tomorrow. Too much is at stake, and too much calamity could occur if Mr. Trump were to be elected. We simply cannot afford to place a giant question mark into the Oval Office, especially a one that has the intellect of a baboon.


text:
Jesse Frank
Custer High Custer, SD Class of 1990
Memories of Jesse Frank
Are you Jesse Frank?
This page means someone is someone is looking for you. Register for free to let other alumni contact you and more:
- Let others find you
- Contact old friends
- Share photos and memories with other registered alumni
Looking for Jesse Frank?
This is a placeholder page for Jesse Frank, which means this person is not currently on this site. We do suggest using the tools below to find Jesse Frank.
About placeholder profiles
You are visiting the placeholder page for Jesse Frank. This page is here because someone used our placeholder utility to look for Jesse Frank. We created this page automatically in hopes Jesse Frank would find it. If you are not Jesse Frank, but are an alumni of Custer High School Custer, SD, register on this site for free now.


text:
What is Functional Diagnostic Nutrition?
Functional Diagnostic Nutrition® (FDN) is a fundamental way of looking at health, a type of detective work that seeks to identify the underlying causes of disease instead of treating symptoms. We try to avoid diagnosing and treating disease, and try very hard to help each patient or client "rebuild health", allowing us to help just about anybody in any condition. We use high quality functional lab work to investigate underlying malfunctions of the adrenal glands, mucosal barrier, detoxification systems, metabolic processes, absorption and assimilation, immune and defense mechanisms and steroid hormone balance to name a few. We identify healing opportunities and engage each client in a health building process using the potent, proven, professional protocols in our D.R.E.S.S. for Health Success program. This includes Diet, Rest, Exercise, Supplements and Stress Reduction. This natural, holistic approach yields the highest level of positive clinical outcomes. We don't medicate, we educate!
"FDN is an emerging field and growing body of work that bridges the gap between clinical nutrition and functional medicine." - Reed Davis, Founder of Functional Diagnostic Nutrition®
Do you know what's wrong with me?
Yes, you have malfunctions at the root of your health complaints which we can identify using functional lab work. Most clients have no idea what is causing their health complaints and neither do their doctors. Many people have been chasing their symptoms for years because other providers can't find the cause or don't bother to even look for it. FDN health detectives use functional diagnostic lab work to identify malfunctions at the causal level and engage our clients in a healing process.
Can you help me?
Yes, as long as you are as committed to restoring health as we are. We're here for all the right reasons. FDN protocols are based on healing opportunities, not treating symptoms. It takes time to rebuild, repair or restore normal function to ones cells, organs or systems. Balancing body chemistry, detoxification, improving digestion and assimilation and immune boosting each come with challenges that require persistence and possible course corrections. Restoring hormone balance may happen soon in some people and take more time in others due to how we each respond to our own chronic stress factors.
Have you helped others like me?
Yes. We've helped thousands of people reach their best level of health in many years. Many clients have completely resolved their health conditions even if they were previously diagnosed with serious medical conditions.
How will I know you are the right coach for me?
During our initial conversations and/or discovery session, together we will identify if this is an appropriate fit. So, before you say "yes", you will have a sample of what the coaching experience will be like. Until then, click on my BIO page to learn more about myself and my approach in coaching.
How do I get started in the coaching process?
If you are interested in beginning the coaching process, please click here to schedule so we can arrange our free 30-minute initial Health Discovery Session to further explore the details of the coaching relationship.
What can I expect from you as my coach?
- Be a partner in bringing out the best, the deepest, and the truest in you;
- Provide safety, encouragement and support; an environment in which you can relax and explore;
- Respect the confidentiality of the agreements we make;
- Expand your view of what is possible and promote discovery of new insights;
- Give you input, straight feedback and operate as a sounding board;
- Listen carefully to what you say and ask questions that increase awareness;
- Be an on-going resource for you in accomplishing your intentions.
What is the FDN Process?
1. Complete Health Evaluation - During our initial meetings, we will discuss your health history, along with your current health complaints, wellness goals, nutrition, and any current medications and supplements you are taking. These are in-depth discussions, so you are urged to spend some time prior to our meetings making a list of questions, concerns, and observations concerning your health. I consider all information pertinent to your health, so the more detailed you can be the better. Based on our discussions, I will recommend certain functional lab testing, which may include saliva, urine, hair, blood, or stool samples. Most lab samples are very easy to obtain and are completed in the convenience of your own home. The lab results will provide us with a current and thorough assessment of how various systems in your body are functioning.
2. Custom Tailored Plans - After you have completed the recommended lab testing, I will create a comprehensive analysis of the results. These results will reveal the biochemical and metabolic imbalances that are behind your current health complaints. I will also tailor a program to address these imbalances that may include education pertaining to natural and botanical supplements and remedies, as well as lifestyle factors such as stress management, diet, sleep, appropriate exercise, and adequate hydration.
3. Investing in Relationships - Due to the unique nature of each client's underlying health issues, there is no preset length of time we will need to work together, but do expect to work closely with me for a minimum of 3 months. My approach is built on a foundation of shared commitment between client and practitioner. I will be with you each step of the way to encourage you, track your progress, focus your efforts, and empower you with the latest tools and information so you can make informed lifestyle choices and take an active role in your future health.
Full Disclaimer
The information presented on www.CreativeBalanceHealth.com is not intended to provide medical advice or take the place of medical advice and treatment from your personal physicians. Please click here to see Full Disclaimer.
Is this client center and my data secured and safe?
Yes! In fact, there are 3 levels of security: provided to keep your data safe and confidential:
- Username and password protected;
- Verisign Security Certificate protects your data on this site;
- Secured pages (https://)
Is my information confidential?
Yes. This site is protected by a username/password system. You are the only one that has access to your information.
Can I contact you in-between our scheduled coaching sessions?
Yes! In the event that you would like support on something that comes up in between our meetings, you can post an inquiry to the Client Log and we can have "just in time" coaching via your Private Client Website.
What is the "Register Now" link and when would I use it?
If you are interested in becoming a client or beginning the coaching process, you can create your own account to access the private client area. When you "register" I will be notified that your account has been created and will need to activate your account. This could take up to 24 hours.
How do I access your private client area and how do I log in?
Click on the Login link in the navigational menu of the website. Then enter the username and password that has been assigned to you. Don't have login information yet? Contact me so we can get an account created for you.
I have a password that I use for most of my on-line accounts. Can I change the password you assigned to me?
Yes. You will need to log in initially using the password I assigned to you. Once you log in, you can change your password at any time in your Client Profile page, that you find under the FORMS tab.
What if I forget or lose my password and login information?
If you simply forgot your password, you can still go to the Login page by clicking the Login link. Click on the blue link "forgot password" to the right of the "Login" button and, in the new "Forgot Password" window, enter your username and click on the "Continue" button. You will receive an email shortly with your password included.
If you misplaced both your username and password, contact me and I will forward you your information.
I'm trying to log in, but it will not accept my username or password, what do I do?
Remember that the login information is case sensitive, so enter it exactly like it was given to you. Also, type in your login credentials and DO NOT copy/paste it, as this procedure can include empty spaces, which count in a password, thus rendering incorrect. Again, if you do not remember your login credentials, you can contact me via email and I'll forward them to you.
What makes up a "Welcome Packet" and what do I do with this?
A welcome packet consists of some basic forms, documents and resources that will help to get us started in the coaching process. By completing the information in the welcome packet, you are providing me with some helpful information, so that I know best how to support you, guide you and work together with you. It includes a "Client Profile" form, a "Goals" form and also a "Discovery" form. You will also find our coaching agreement located in this packet. It is customary for you to complete these items prior to our initial coaching session together.
What if I need to reschedule my appointment?
It's easy. With at least a 24 hour notice, you can reschedule any appointment by using the online calendar system. Just complete the following steps:
- Log into your Private Client Website Area.
- Click on the Calendar Menu.
- Locate and click on the desired block of "Available" time (or if you already have an existing appointment, click on the title of your existing appointment that you wish to reschedule)
- Click on the "edit" button and change the details of the appointment to correspond with an "Available" block of time.
- The calendar will update itself, you'll see your new appointment reflected and I will receive an email notification letting me know of the change.
How do I easily make my payments for my coaching services?
Each month you'll receive an invoice from my practice letting you know the amount committed to for that month. You can (1) mail a check to the remit to address located right on the invoice or (2) log in to the private client area, click on the Payments Menu and you will see any outstanding balances due at that time.
What are the various methods of payment I can use to pay for my coaching services?
PayPal is preferred. Check, Cash, Waived, or Barter.
- To pay by PayPal: when you receive your monthly invoice, click on the link at the bottom of the invoice to log into the private client area and click on the Payments Menu. Here you can either enter your Pay Pal information and my system will automatically (and securely) process your payment.
- To pay by Check: simply use the "remit to" address located to the right in the body of the invoice you'll receive monthly from my practice.
In the event of the Client's absence or withdrawal, for any reason whatsoever, the Client will remain fully responsible for the unpaid balance of the consultation(s). Under no circumstance will the Health Coach refund any payments made by the Client. With payment of the first consultation session this Agreement will commence, the Client agrees to be legally obligated to pay the full amount of all consultation sessions agreed upon. The client may "gift" the paid for sessions/program to another person of their choice if they wish. Any "gifting" of sessions must be made in writing with all parties in agreement and the gift receiver will be required to sign a program agreement acknowledging all other aspects of the terms of service.
If you make a mistake collecting saliva or urine specimens, etc., or if the lab refuses to accept specimens because of a mistake you made, a free replacement test kit will be provided to you. Please call the office before discarding any specimens collected. Otherwise, once test kits are in your possession, they may not be returned and no refunds are allowed for any test kits due to safety, hygiene and accuracy concerns.


text:
Thames Valley Escort Lexi
Escort in Thames Valley LEXI is a naughty and dirty toned and tanned sex maniac with a sexy slim figure and pretty face. Add some Razzle Dazzle to your sex romps she is scorchingly hot you will sizzle. She has the power to tip you over the edge sexually and have you coming back for more. She offers all services A is discretional. Offering In-Calls xx


text:
Went to Lowes and Home Depot today to check out their perennials. It's still really early, but I found a few things.
The haul.
I'm trying to fill up the little roadside garden. I planted Mediterranean pink heather, sedum 'Stonecrop', lithodora 'Heavenly Blue', and stachys 'Silver Carpet'. I also planted a hardy geranium 'Striata' that I never got planted last year.
Planted hollies in pots and geraniums. I'm thinking of toning down the blue doors with some stain. I really just need new front doors.
I also bought lettuce seeds, gourmet greens mixture, and sunflower seeds.
I moved my good and evil girl.
Pitiful pansies! I haven't finished weeding this garden. I'm hoping to fill it up with lots of foxgloves and other cottagey flowers.
Bad chicken!
Sunday, March 22, 2009
Saturday Jumpstart
Went to Lowes and Home Depot today to check out their perennials. It's still really early, but I found a few things.
Posted by karenleigh at 4:59 PM
3 comments:
- Lynda said...
The chickens are adorable!It looks like you hit the jackpot of great flowers to plant. I too have been hunting for flowers at garden stores, I have planted the shirley Poppies, Forget me nots, and am ordering my David Austins and seeds for Nicotiana Sylvestris!
- March 23, 2009 at 12:45 PM
- Bangchik and Kakdah said...
Oh.. I cant rear chickens where I live now..... yours a nice plot!... cheers ... ~ bangchik
- April 3, 2009 at 6:53 AM
- Mary said...
Thanks for your note! It's definitely spring, isn't it? Here in Charlotte they are forecasting a freeze this week. Oh, gosh.
I like your shopping spree! I'm going to wait a little while longer.
That chicken! LOL!
- April 4, 2009 at 10:12 PM


text:
I really love the Follia chair from Retro-modern. It looks like an end table with stainless steel attached that connects to a backrest. The contrast between black and stainless highlights differences and yet provides fluidity in style. This chair was created for the Casa del Fascio in 1934 by Italian designer Guiseppe Terragni. The Casa del Fascio is an office building in Como, Italy which opened in 1936 for which Terragni was the architect. Guiseppe used some of the same structural and plane concepts in design of the chair as he did in the office building. The chair retails for $1,910 at Retromodern.
Hits: 0


text:
News and Events
16.03.2012 Malta will celebrate eight years since joining the European Union
On April 23 the 11th International Firework Festival will take place in Malta, reports Geo Meridian portal.
During the week the best local and foreign pyrotechnics specialists will show their skills.
In connection with the 8th anniversary of joining EU, this year event will be especially grandiose. The opening ceremony will be held in the city of Mdina, while the main events will traditionally occur at the capital of the Malta Island, Valetta. The festival will include a lot of fireworks show with laser special effects, concerts and some other entertainments. Particularly, colourful fireworks will illuminate the sky above St. Paul's Bay and Gozo, as well as in the Great Harbour of Valetta.


text:
Login from the address below:
The email you received has your username and password. We recommend changing your password when you first login and then frequently.
You can also login via your SOCS sports website, SOCS school website or SOCS calendar website, dependent on which of these are configured for you school. The SOCS login button is normally located to the top right of the home page as shown in the example below, which shows the home page of the standard, uncustomized, SOCS sports website:
Please note, if you have a customized sports website your login button may appear in a different format and location on the page.
If you have forgotten your password, click the 'FORGOT PASSWORD' button on the login page and enter your email address. You will then be sent an email with a link allowing you to reset your password.
You can also login from any of our sport portals where you see a SOCS login button. The sport portal can be found here:
Click here to return to SOCS sport: Getting Started


text:
Drauquerung – Koralm Railway Route Graz–Klagenfurt
In the course of the project Koralmbahn the current bridge MA 26 (Drauquerung) crosses the Drau valley in the area of the Völkermarkt water reservoir.
As part of the future direct connection between Graz and Klagenfurt, the double-track bridge bearing structure is built for a design speed of 250 km/h. The structure, which has a total length of approx. 600 m, consists of four single bearing structures with spans between 125 m and 200 m.
The bridge structure itself consists of a pre-stressed box girder cross section. The load transfer into the underground (foundation) is performed by classical deep foundation by large bored piles.
The bridge structure is constructed by means of incremental launching (insertion of the structure) where the four single bearing structures are monolithically connected by a temporary connection in the course of insertion. The single bearing structures are separated after the insertion procedure in the end position.


text:
|Alan Ford Architects P.C
|(Submitted: 8/31/2008 7:08:37 PM)
|Description :
|Design practice grounded in finding architectural solutions within the context of the existing environment, culture and climate. The firm's mission is to create architecture of distinction that enhances the quality of life through high quality design and detailing combined with a long-standing commitment to sustainability.
|Service Region :
|Colorado; nationwide
|Address 1 :
|3457 Ringsby Court, #217
|Address 2 :
|City :
|State :
|Postal Code :
|Website :
|Contact Name :
|Alan Ford
|Contact Email :
|Contact Phone :
|Contact FAX :
Hot Issues | Tips & Information | Communications Center
Calendar of Events | Colorado Activities | Energy Directory | Energy Data
Laws/Legislation | Professionals Corner | Job Announcements
Other Sites | About COenergy | Search | Home
© 2000-2010 ColoradoENERGY.org
This site is currently maintained and hosted by Randy L. Martin of R. L. Martin & Associates, Inc.
Comments on the site and notification of items that could be included can be sent to: email


text:
Contact Me
You can reach me by calling me on 01276 919734 or by sending me an email with your name and telephone number, even if you have not decided to commit yet and I will call you back at a time to suit you. I offer a free 30 minute initial consultation so that you can find out more.
Janet Elliott
If I can help you with a short answer, just use this e-mail form:


text:
Dulion charpente
Access map
Visit us
Opening Hours
Restoration of specific structures (carousels, presses and panelled arches), fitting of complex staying, graft and scarf joint restoration, timber frame, belfry and framework structural restoration, renovation of hydraulic structures (valves, lock work).
It possesses outstanding know-how. It uses traditional processes: wood cutting (tracing, plumb bob scribing, haunched tenon assembly, tenon and mortise assembly, dowelling, etc.), finishing of wood facings using traditional tools (plane, adze, etc.), use of antique wood. The company initiated a partnership with the Auxerre Centre for medieval studies, performing wood frame dendrochronologies in collaboration with specialists.
The company operates mainly in Bourgogne, Champagne-Ardenne and Ile de France. It caters to the needs of individuals and institutions in charge of building maintenance: Departmental councils, municipalities, DRAC (Regional Cultural Affairs Directorate), etc. It works in particular for head architects of Historical Monuments and Heritage architects.


text:
SSIS : Using the VariableDispenser object within Script Components
I have become accustom to modifying package variables within my Script Task using theVariablesDispenser object. It is convenient and powerful. I started working with this object due to issues I found while hacking my way through SSIS2005. I would put the variables in the ReadOnly or ReadWrite section and would get weird errors attributed to exclusive locking..blah,blah,blah. I naturally carried this practice over to SSIS2008 and things work the same; in the Script Task.
Getting heavily involved in SSIS development I broke down and decided to do more Script Component work. Prior to SSIS I had done my absolute best to keep away from VB.Net and along with that, Script Components. I just didn't like the way VB 'felt'. To be honest, there is nothing wrong with choosing or avoiding a language based upon personal preference, so long as the language chosen is proper for the job. Seeing C# as an option in SSIS2008, I decided that would be my language of choice and was once again excited about getting into ScriptComponents to begin developing again.
My first foray back into programming Script Components, I had a hard time using the VariablesDispenser in the Script Component. I couldn't find the Variables object. Thinking there had to be an easier way, I went back to using the ReadOnly/ReadWrite Variables property. This wasn't much easier. Turns out, these variables can only be accessed within certain sections of your Script Component. ReadWrite variables are available through the Variables object in the PostExecute() method only:
ReadOnly variables are only available to the Variables object in the PreExecute() method. I also found some interesting bugs regarding this (see previous post script gotchas).
This worked fine for me, but being more stubborn than smart, I wanted to figure out a way to access these variables the way I was most comfortable, using the VariablesDispenser. A few sleepless nights later I found what I was looking for;IDTSVariables100 object.
You no longer access the VariableDispenser object through Dts and you no longer pass in the a variable of type Variables. Instead you access the package level variables directly through VariableDispenser and pass all of the locked package variables into a local variable of type IDTSVariables100.
"So what does this buy me?". First, I am not constrained to have my ReadOnly variables accessible only in the PreExecute() method and my ReadWrite variables accessible only in the PostExecute() method. This means I don't need local variables to pass information around or keep counts of things to later push out. This is really only useful in Script Source and Script Destination objects where you don't loop through the methods for each row. It's also easier to copy/past the code in the above example to move to it multiple scripts vs having to hand code each script's ReadOnly/ReadWrite section. Last, but not least; personal preference.


text: Catherine & Bill_Winter Wedding Photography_Banff Spring Hotel Wedding_Royal Suite Wedding_Lake wedding_Rocky mountain wedding October 17, 2016 Posted in Banff/Canmore Wedding Photographers, Best Wedding PhotographyNo comments Catherine and Bill's wedding in beautiful Banff Fairmont. Their love story will come soon. Tags: Banff and Lake Louise Wedding Photography, Banff Town Wedding Photos, banff wedding photographers, Banff Wedding Photography, Fairmont Banff Spring Hotel Wedding Photographers, Fairmont Banff Springs Hotel Wedding, fairmont winter wedding photography in banff, wedding photographers banff, Yueko Image photography « Eldee & JC Model Shots_Bragg Creek Portrait photography_Elbow Falls Portrait photography Claudia & Juan's Wedding_Sun bowl wedding_Calgary Baker Park Wedding_Winter Outdoor Wedding » no comments email a friend Your email is never published or shared. Required fields are marked * Name * Email * Website Comment


text:
We are a Boutique.
We do not want to represent the most Buyers or the most Sellers
Our Service is different. We have no ambition to sell the most homes, or to represent the most Buyers. We are content being acknowledged as Boutique Realtors who serve a limited number of clients with exceptional service within a large company like Coldwell Banker. We utilize their resources and global reach to best serve our clients, while giving a genuine boutique service.
Focus on the Seller.
To be candid, we actively promote our services to represent new Sellers, but we do so under self-restraint. Our goal is to offer our listing service in two geographic areas; the Newport Coast communities of the Newport Ridge and Balboa Island. However we will list a previous client's property anywhere in Coastal Southern California.
Focus on the Buyer.
We do not restrict ourselves geographically when it comes to representing Buyers. We have represented clients in every community in Newport Beach, Corona Del Mar, Costa Mesa, and most of the Newport Coast communities. Additionally we have executed transactions in every city and all of the premier communities of Orange County from Sunset Beach to Cottons Point in San Clemente, from Anaheim Hills to Coto de Caza.
Focus on our Clients.
We remain committed to providing our clients with exceptional service wherever they require it. When our clients need to go beyond Coastal Orange County, we ensure that we introduce them to like-minded Agents from La Jolla to Malibu, from Carmel by the Sea to San Francisco, or Lake Tahoe to Sun Valley Idaho. Our clients are loyal to us, and we are dedicated to our Clients.
Focus on Service
We give our clients the utmost in personal care one transaction at a time and the only bottom-line that we concern ourselves with is our client's bottom-line. Please contact us and find out for yourself how successful our Boutique real estate service is, and how you will succeed as our client.
|Discrete Marketing
Our Office
333 Marine Avenue #6
Balboa Island, CA 92662
Driving Directions
Patrick Bartolic
CalRE No. 00783792
Email: email@example.com
Tony Bartolic
CalRE No. 01193486
Email: email@example.com
Erin Bartolic
CalRE No. 02043980
Email: firstname.lastname@example.com
Lauren Disberger
CalRE No. 02061372
Email: firstname.lastname@example.com
Coldwell Banker Residential Brokerage


text:
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
Prostate cancer (PC) is the second most common cancer diagnosis and the fifth leading cause of cancer mortality in men (1). In 2012, 1.09 million men were diagnosed worldwide, thus representing a substantial public health burden. The use of prostate specific antigen (PSA) testing and improvements in diagnostic procedures such as imaging and ultrasound guided biopsy have led to a significant increase in early diagnosis of localized, low-risk PC (LRPC), ranging from 10–80% of all men diagnosed with PC worldwide (1), and a subsequent decrease in PC mortality (2-4).
A substantial proportion of men with LRPC do not need treatment with surgery or radiation, but can be carefully monitored—an approach known as active surveillance (AS). Overtreatment of LRPC is of concern, not only because of the physical and psychological morbidity associated with radical treatment, but also because of the economic healthcare burden (5,6). AS is considered a safe alternative to immediate treatment and is endorsed by national medical organizations and guideline groups as a viable management option for men with LRPC (7).
More specifically, AS for LRPC can be defined as a treatment strategy of close monitoring through blood tests (PSA), digital rectal examination (DRE), imaging and prostate biopsy, with conversion to curative treatment if progression occurs (8,9). Large cohort studies have shown that with appropriate patient selection, risk of dying from PC in men on AS is low: 0.1% to 5.7% over 10–15 years (Table 1). However, inconsistency in selection and adherence to AS remains. Studies suggest that patient preference (23,24), physician (25,26), family and peer group influence (27,28), National guidelines (29,30) and local practices (31,32) all influence this process. There is also no doubt that anxiety surrounding disease progression also plays a significant role (33-35) in influencing long-term AS adherence. It is reported that cancer continues to cause more fear than debt, knife crime, Alzheimer's disease and unemployment (36). Unsurprisingly therefore, studies continue to report that 1.6% to 38% of men opt out of AS often with no or little evidence of disease progression within 5 years (Table 1).
Full table
However, in the last 10 years a trend towards AS adoption in LRPC has been reported by many large database studies, with some variation still noted between countries, practices and physicians (37). Most notable are the upward trends seen in North America, Australia and Europe. In 2015, Cooperberg and Carroll reviewed US trends in AS reporting from the US CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) database. This demonstrated a sharp rise in the uptake of AS, from 10% over the past 20 years to 40% in 2010–2013 (4). This was replicated in Europe with the Swedish National PC Register reporting a rise from 40% to 74% between 2009 and 2014 (30) and in Australia, where the Victorian PC Registry (38) reported a 16% rise in AS uptake between the first half of 2010 and second half (23.9% to 39.7%). This level (39%) was maintained over the following 2 years further increasing in 2015 up to 42.8% (39). This was also demonstrated in hospitals reporting on radical prostatectomy in both Canada and Germany. In Canada (Toronto), Louis and authors (40) reported a steady decline in the number of radical prostatectomies carried out for LRPC from 2007 (40.6%) to 2012 (13.6%), whilst in Germany the Martini Clinic (41) demonstrated a similar decrease for low-risk Gleason score 6 cancer in 2014 (12.1%) in comparison to 52.2% in 2000.
However, this increase is not universal. In contrast, a 2014 survey (42) of 2,133 Japanese urologists suggested that 26.9% reported no use of AS for LRPC and another 50.6% reported using AS in <5% of their patients. Moreover, only 27% of respondents indicated that they would want to offer AS more frequently in the future.
The increased use of AS seen in some countries suggests that the global trend towards conservative management for LRPC is gathering pace, however the fact that there is no worldwide consensus on defining favourable risk disease (43) in AS suggests that there is still some way to go in gaining universal acceptance.
This review aims to evaluate the literature describing contemporary AS practices worldwide and explores the importance of Movember's GAP3 (Global Action Plan Prostate Cancer—Active Surveillance) collaborative effort in answering the key questions: what defines safe patient selection? What should the surveillance strategy look like? What clinical triggers are important in recommending radical treatment?
Search strategy
Studies documenting AS cohorts with a minimum of 5 years' follow-up published before October 2017 were identified through a systematic search of electronic databases (PubMed/Medline 2000-now and Embase) using the following key search terms: "prostate cancer", "active surveillance", "follow-up", "cohort", and their relevant synonyms. Cited references were searched and retrieved for potentially eligible publications.
Studies of primary interest were those describing baseline and clinical characteristics of the study population, patient selection criteria, monitoring/surveillance protocol, AS drop-out, triggers for conversion to radical treatment and outcomes during follow-up (5-year studies with a median follow-up >18 months).
We identified 119 unique citations; of these 83 were excluded as review articles, commentaries, narratives, abstracts or where median follow-up was less than 18 months. Full-text screening was carried out on 36 articles, of which 23 were excluded, rendering 13 articles included (Figure 1—PRISMA diagram) each describing a unique AS cohort. Of the 13 included cohort studies (10-22), 6 took place in North America (10-12,14,17,21), 5 in Europe (15,16,18,20,22), 1 worldwide (13) and 1 in Australia (19).
The general demographic and follow-up characteristics of the published AS cohorts in this review vary considerably (Table 1). The average age across the studies was 65 years old. The number of participants studied ranged from 238 to 2,494 men. The number of months' follow-up ranged from 19 to 180 months.
The main findings in terms of AS adoption/patient selection, monitoring protocols and trigger points for intervention or re-assessment across the different AS studies are described below.
AS patient selection
Thirteen international AS programmes met our inclusion criteria, describing guidelines for AS patient selection (Table 2). These are described with respect to selection criteria based on the following components: (Tumour Nodes Metastases) TNM stage, PSA level, PSA density, percentage of cancer in prostate cores, number of positive cores and Gleason grading.
Full table
TNM stage
All cohorts agreed eligibility for AS meant clinically localised PC, with half of the cohorts using T2a or less, two [John Hopkins (11) and Goteborg (20)] opting to follow the Epstein criteria of T1c (in at least one arm of their cohort study). At the other end of the spectrum, three studies also included patients with T2b [(St Vincent's, Australia (19), Canary PASS (21) and Milan (22)] and two cohorts men diagnosed with T2c disease [Canary PASS (21) and Milan (22)].
PSA level
Agreement between ten of thirteen cohorts suggested a PSA cut-off of 10 µg/L, the University of Toronto (17) and Royal Marsden (15) suggested an upper limit of 15–20 µg/L depending on life expectancy and age (>65 years) respectively. Only Goteborg (20) and Canary PASS (21) suggested an acceptable PSA for intermediate-risk disease of <20 µg/L.
PSA density
PSA density was featured in five cohorts (11,13,20-22). However, there was no consensus, with Milan (22) and PRIAS (13) suggesting a cut off of 0.2 and John Hopkins (11), Goteborg (20) and Canary PASS (21) opting for a more conservative 0.15.
Gleason grading
All included cohorts defined entry into AS as men with low-risk disease—Gleason 3+3 or less. The Canary PASS (21) and Goteborg cohorts (20) defined an entry criteria for men with intermediate-risk disease as Gleason 3+4, whereas The Royal Marsden (15) suggested men over the age of 65 were acceptable for entry into AS with Gleason 3+4.
Number of positive cancer cores
There was more agreement between institutions on the number of positive cancer cores (11 cohorts), which ranged between 2 and 3 cores in most cases. University of California San Francisco (UCSF) (12) suggested the number of cores should not exceed 33% of the total number of cores taken and the St. Vincent's Australia (19) cohort criteria suggested 20% as a reasonable cut-off.
Percentage of cancer in prostate core
Five of thirteen cohorts [Memorial Sloan Kettering Cancer Center (MSKCC) (10), Johns Hopkins (11), UCSF (12), Royal Marsden (15) and Milan (22)] agreed that no prostate core should contain more than 50% cancer with three cohorts [University of Miami (14), St Vincent's Australia (19) and Canary PASS (21)] suggesting a more conservative 20–34% (14,19). Five cohorts made no mention of percentage of PC in cores and therefore it is assumed this was not part of their selection criteria.
Monitoring protocols (Table 3)
Full table
Following initiation of an AS programme, most guidelines recommend serial serum PSA measurements, DRE and surveillance biopsies to check for and identify indications of tumour progression (Table 3).
Of the thirteen studies, DRE as part of the surveillance strategy played an important role in nine [MSKCC (10), John Hopkins (11) UCSF (12), University of Miami (14), Royal Marsden (15), University of Copenhagen (UCPH) (18), St Vincent's Australia (19), Goteborg (20) and Canary PASS (21)] with the frequency ranging from 3 to 6 monthly.
All studies carried out PSA testing, but again protocols ranged from 3 to 6 monthly. Only MSKCC (10) recommended a 6-monthly free to total ratio PSA as useful.
Prostate re-biopsy
Eleven studies carried out confirmatory biopsies within a year of initial diagnosis, whilst the Royal Marsden (15) cited acceptability within 2 years of AS initiation and ProtecT (16) required no repeat biopsy. All studies demonstrated differences in the frequency that biopsies were repeated thereafter. Two centres [John Hopkins (11) and University of Miami (12)] routinely biopsied annually, with the others ranging from 2–3 yearly or on clinical progression. Only the ProtecT study (16) did not perform routine and regular re-biopsy. UCSF (12) was the only institution to carry out regular trans-rectal ultrasound without biopsy.
General health assessment
Regular routine general health assessments were undertaken in two studies [MSKCC (10) and Canary PASS (21)], as a possible criterion for switching to watchful waiting (WW), with only MSKCC indicating that they carried out regular lower urinary tract symptom assessment. Two centres [University of Toronto (17) and St Vincent's Australia (19)] indicated that they switched patients from AS to WW at 80 and 75 years old, respectively.
Triggers for intervention
At 5 years of follow-up, the proportion of men treated ranged from 14% to 50% across all of the studies. The proportion of men who developed metastatic disease was low across all studies, in the Johns Hopkins cohort (12) for example; this was recorded as 0.1% and 0.6% at 5 and 15 years, respectively. The PC specific mortality rates were also low ranging from 0.2% to 5.7% (10,17) (Table 1).
Definitions of disease reclassification and progression differ across national guidelines and the AS cohorts described here are different. Many of the cohorts describe changes in one or multiple criteria for initiation of definitive treatment (Table 4).
Full table
Pathology (Gleason score)
Amongst the 13 cohorts reviewed here, 8 studies [MSKCC (10), John Hopkins (11), UCSF (12), PRIAS (13), University of Miami (14), St Vincent's Australia (19), Canary PASS (21) and Milan (22)] triggered intervention in LRPC if subsequent pathology was Gleason score >6. In the Canary PASS LRPC group radical treatment versus continued AS (with re-classification as intermediate-risk) were discussed as options. Two [University of Toronto (17) and Goteborg (20)] suggested any pathological upgrade would trigger intervention. Two cohorts [Royal Marsden (15) and UCPH (18)] identified a Gleason score of ≥4+3 as the trigger point. Only Canary PASS (21) and Goteborg (20) gave a weighting depending on very low-risk/low risk (Gleason >3+3) or intermediate/High-risk (Gleason ≥3+4) disease.
Number/percentage of positive cores
Five of the thirteen studies [MSKCC (10), UCSF (12), PRIAS (13), University of Miami (14) and Milan (22)] maintained that >2 cores positive should trigger treatment, with the UCPH (18) extending this to >3 cores positive. St Vincent's Australia (19) suggested that cancer found in >20% of any positive core should trigger intervention, whilst The Royal Marsden (15) and Johns Hopkins (11) suggested a higher threshold for triggering treatment: 50% and 33% respectively. The remaining studies gave no indication of cut-off based on number of cores positive. The maximum cancer length (MCL) was variable, with two centres [MSKCC (10) and John Hopkins (11)] suggesting a cut-off of 50% and two centres suggesting more conservative numbers; St Vincent's Australia (19) suggesting a cut-off of 8 mm of cancer and the Canary PASS consortium was set at ≥34%. The University of Miami (14) defined any increase in volume of PC and in MCL as their trigger for intervention.
PSA-based triggers for intervention included PSA doubling time (PSAD) and PSA velocity (PSAV). Only two studies suggested PSAV as an important trigger, The Royal Marsden (15) suggesting a PSAV of >1 and St Vincent's Australia (19) >0.75. PSA doubling time was included in six studies [UCSF (12), PRIAS (13), University of Toronto (17), UCPH (18), St Vincent's Australia (19) and Milan (22)] with a cut-off of 3 years. The Goteborg group (20) defined the trigger as any PSA progression.
Summary of systematic review
The thirteen AS cohorts included in this review demonstrated a wide variety of descriptions of LRPC. This indicates a clear lack of consensus on defining favourable risk disease, suitability for AS and intervention thresholds.
Patient selection (Table 2): despite all studies agreeing that a clinically localised PC diagnosis was defined as T2 disease and the majority of studies agreeing on a PSA threshold of <10 µg/L and Gleason score 3+3 (3+4 in intermediate risk disease), there was significant inconsistency in practice when considering pathology (i.e., the number of acceptable positive cores and MCL).
Monitoring protocols (Table 3): all studies agreed on PSA surveillance with a frequency ranging from 3 to 6 monthly and most agreed that a confirmatory biopsy was required within 12 months after AS selection, however, no consensus was reached on the importance and relevance of DRE or re-biopsy strategy.
Triggers for intervention (Table 4): the cohorts described here appear cautious in their definition of disease progression, with low tolerance for increasing PSA defined as "any" or number of positive cores, cancer volume, and/or change in Gleason score. There was no universal agreement on triggers for intervention although, agreement was reached on Gleason score >6 in 62% of studies, number of percentage increase in positive cancer cores was identified in 69% of the cohorts, MCL and PSA doubling time of <3 years was used in 46% of the studies.
A narrative review performed in 2016 showed that existing guidelines regarding AS for PC vary widely, but predominantly state that the most suitable patients for AS are those with pre-treatment clinical stage T1c or T2 tumours, serum PSA levels <10 µg/L, biopsy Gleason scores of ≤6, a maximum of two tumour positive biopsy core samples and/or a MCL of 50% per core sample (44). The heterogeneity in practice demonstrated in this narrative, further highlights the need for a robust collaborative worldwide prospective study to finally determine safe patient selection, monitoring and appropriate triggers for intervention.
The future of AS
The use of magnetic resonance imaging (MRI) in the context of AS varies between practitioners, countries and healthcare systems. Current European (45) guidance on prostate MRI concentrates on its role in the detection and staging of PC. Little evidence has yet been published supporting more generalised use in the context of AS.
This may explain why only two of the thirteen cohorts reviewed [the Milan arm of the PRIAS study (22) and University of Toronto] used MRI to support AS at the time of reporting. The Milan group used MRI imaging routinely (from 2015) as an adjuvant to the AS selection criteria, opening up AS selection to men with negative MRI scans. No limit was placed on number of positive cores in patients with negative MRI's or where targeted biopsy shows 3+3 disease only. The University of Toronto used MRI as a conduit to triggering intervention. Where patients had a PSADT of <3 years, MRI and/or repeat biopsy was used to clarify the need for treatment.
In 2015 a systematic review of MRI use in AS found only seven studies addressing MRI reliability in relation in selecting patients for AS using biopsy correlation and two studies focused on the use of repeat MRI in AS (46). This review was hampered by the small number of patients in the included studies as well as the low number of studies. It was concluded that MRI could detect clinically significant PC, however as of yet MRI cannot be considered as an alternative to repeat biopsy in long-term monitoring on AS without further evidence from robust prospective studies.
Despite the paucity of evidence, in 2014 the UK National Institute for Heath and Care Excellence (NICE) PC guidelines (8) suggested a role for MRI in AS, but without any guidance on the criteria for radiological significance and progression. With this in mind, the European School of Oncology recently reported the PRECISE recommendations (47) for MRI usage in AS, with the aim of facilitating the development of a robust evidence base for documenting changes in prostate MRI findings in men on AS over time. This checklist will allow for better assessment of the natural history of MRI change in men on AS.
The role of nomograms in AS
Nomograms have been successfully used and integrated into healthcare setting as an assist to both patients and clinicians in establishing risk and aiding decision making. There is widely accepted usage of nomograms in PC diagnosis (48,49). However, predictive nomograms for indolent disease in the context of AS have been less successful (50). In 2016 Venderbos and colleagues studied participants of the European Randomized study of Screening for PC (ERSPC) (51) to establish whether a probabilistic nomogram could improve patient selection for AS compared to a rule based criteria. They reviewed men initially diagnosed with histopathological indolent PC at radical prostatectomy [defined as pT2, Gleason pattern ≤3 and tumour volume (TV) ≤0.5 mL or TV ≤1.3 mL] to develop an existing nomogram to provide probability-based data and compared this to rule-based selection according to the PC Research International: Active Surveillance (PRIAS) (13), University of Toronto (17), and Johns Hopkins (11) criteria. The performance of the nomogram, using the Johns Hopkins (11) and PRIAS (13) rule-based criteria's, were found to be comparable and could prove a good alternative to rigid rule-based surveillance protocols where patients request more information on probability of progression to make informed decisions on treatment.
Global action plan PC active surveillance (GAP3) initiative
Although AS has evolved to a broadly accepted management strategy for men diagnosed with LRPC, this systematic review of worldwide AS practices confirms there is little consensus on inclusion criteria, surveillance schedules and intervention thresholds. Also, variation in AS semantics used in literature and guidelines could lead to confusion.
To address these issues, the Movember Foundation launched within their Global Action Plan Prostate Cancer Active Surveillance initiative (GAP3) in August 2014 (52). To date, GAP3 has united as many as 25 institutions, hospitals and research centres from the USA, Canada, Australia, Singapore, Japan, Korea, UK, Ireland, the Netherlands, France, Sweden, Finland, Switzerland, Italy and Spain. The primary aim of the GAP3 initiative is to create global consensus on the selection and monitoring of men with low risk PC, ultimately resulting in worldwide uniform guidelines.
Within the GAP3 initiative, the largest centralized PC AS database to date was constructed by combining patient data from 25 established AS cohorts worldwide. This database currently comprises clinical, marker-related and imaging data on more than 15,000 patients. Multiple data analyses of this unique global data set are currently ongoing focussing on three main questions regarding AS: which patients are most suitable for AS, what is the most appropriate follow-up schedule and what is the right moment to switch to active treatment? Based on these results, a peer reviewed publication on consensus guidelines is expected in 2019.
In addition, the GAP3 programme is performing a centralized pathology review of randomly selected biopsies. Preliminary results confirm consistent biopsy quality and grading across the different centres, which would enable data analyses without correction. Moreover, a panel of leading PC specialists in the field of AS was convened to overcome the AS semantic heterogeneity in literature and guidelines (43). By using a modified Delphi consensus procedure including a three-round sequence of online questionnaires and a face-to-face consensus meeting, formal consensus was reached for all 61 individual terms.
Movember has recently allocated additional funding to maintain the database and update the clinical data annually with a special focus on MRI, quality of life and genomics data. MRI is becoming an increasingly important technology for the management of AS. GAP3 aims to also assess the value of MRI with respect to lesion definition and changes over time. Conclusions based on the analyses of patient series published to date are limited due to small size cohorts. Therefore, the need to combine these data is imperative to assess the value of MRI. This also holds true for assessing the use of genomic markers, as well as quality of life in the decision to initially pursue AS rather than active treatment.
In summary, analyses of global AS data within GAP3 will further elucidate the optimal inclusion criteria, surveillance schedules and intervention thresholds and result in more uniform AS guidelines.
This will enable clinicians to more confidently identify men who are suitable for AS and to also decide whose PCa has progressed and will, therefore, require treatment. In addition, this will reassure men of making the most informed treatment decision for their type of disease.
In the last 15 years large cohort studies have progressed the definition of safe AS. Collaborations between institutions [ProtecT (UK) (16) and Canary PASS (US) (21)] and even countries [The PRIAS study (13)] have contributed to our increasing confidence in AS and a demonstrable increase in the number of men selecting AS.
This systematic review shows that AS is being applied. However, implementation of successful AS programmes worldwide needs to reduce the over treatment of PC as well as creating a safety net for men incorrectly diagnosed with indolent disease. Currently, the general Urologist and/or Oncologist may struggle to manage these patients with any degree of confidence, which may explain variations in practice. This confidence requires robust data from large cohorts with long follow-up, such as collected within the GAP3 initiative, to create global consensus on inclusion criteria, surveillance schedules and intervention thresholds.
Funding: Sigrid Carlsson is supported in part by a Cancer Center Support Grant from the National Cancer Institute made to Memorial Sloan Kettering Cancer Center (P30-CA008748), a SPORE grant from the National Cancer Institute to Dr. H. Scher (P50-CA092629), a grant from the National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network (U01CA199338-02) and the David H. Koch prostate cancer research fund.
Conflicts of Interest: The authors have no conflicts of interest to declare.
- Wong MC, Goggins WB, Wang HH, et al. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol 2016;70:862-74. [Crossref] [PubMed]
- Network NCI. Cancer incidence, males, ICD10 C61: Prostate, 2008-2010. National Cancer Intelligence Network (NCIN), UK Cancer Information Service (UKCIS). UKCIS. 2010.
- Van Hemelrijck M, Garmo H, Wigertz A, et al. Cohort profile update: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory. Int J Epidemiol 2016;45:73-82. [Crossref] [PubMed]
- Cooperberg MR, Carroll PR. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA 2015;314:80-2. [Crossref] [PubMed]
- Dall'Era MA. The economics of active surveillance for prostate cancer. Curr Opin Urol 2013;23:278-82. [PubMed]
- Eldefrawy A, Katkoori D, Abramowitz M, et al. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison. Urol Oncol 2013;31:576-80. [Crossref] [PubMed]
- Bruinsma SM, Bangma CH, Carroll PR, et al. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat Rev Urol 2016;13:151-67. [Crossref] [PubMed]
- NICE. NICE Guidelines for the managment of Active Surveillance. NICE. 2014. Accessed 20 March 2014.
- Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 2014;65:124-37. [Crossref] [PubMed]
- Adamy A, Yee DS, Matsushita K, et al. Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. J Urol 2011;185:477-82. [Crossref] [PubMed]
- Tosoian JJ, Mamawala M, Epstein JI, et al. Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer. J Clin Oncol 2015;33:3379-85. [Crossref] [PubMed]
- Welty CJ, Cowan JE, Nguyen H, et al. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol 2015;193:807-11. [Crossref] [PubMed]
- Bul M, Zhu X, Valdagni R, et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 2013;63:597-603. [Crossref] [PubMed]
- Soloway MS, Soloway CT, Eldefrawy A, et al. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010;58:831-5. [Crossref] [PubMed]
- Selvadurai ED, Singhera M, Thomas K, et al. Medium-term outcomes of active surveillance for localised prostate cancer. Eur Urol 2013;64:981-7. [Crossref] [PubMed]
- Hamdy FC, Donovan JL, Lane JA, et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med 2016;375:1415-24. [Crossref] [PubMed]
- Klotz L, Vesprini D, Sethukavalan P, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 2015;33:272-7. [Crossref] [PubMed]
- Thomsen FB. Active surveillance strategy for patients with localised prostate cancer: criteria for progression. Dan Med J 2015;62:B5005. [PubMed]
- Thompson JE, Hayen A, Landau A, et al. Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer. BJU Int 2015;115:884-91. [Crossref] [PubMed]
- Godtman RA, Holmberg E, Khatami A, et al. Long-term Results of Active Surveillance in the Goteborg Randomized, Population-based Prostate Cancer Screening Trial. Eur Urol 2016;70:760-6. [Crossref] [PubMed]
- Newcomb LF, Thompson IM Jr, Boyer HD, et al. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol 2016;195:313-20. [Crossref] [PubMed]
- Marenghi C, Alvisi MF, Palorini F, et al. Eleven-year management of prostate cancer patients on active surveillance: what have we learned? Tumori 2017;103:464-74. [PubMed]
- Volk RJ, McFall SL, Cantor SB, et al. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer. Psychooncology 2014;23:467-72. [Crossref] [PubMed]
- Xu J, Neale AV, Dailey RK, et al. Patient perspective on watchful waiting/active surveillance for localized prostate cancer. J Am Board Fam Med 2012;25:763-70. [Crossref] [PubMed]
- Loeb S, Curnyn C, Fagerlin A, et al. Qualitative study on decision-making by prostate cancer physicians during active surveillance. BJU Int 2017;120:32-9. [Crossref] [PubMed]
- Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns 2012;87:369-74. [Crossref] [PubMed]
- Gorin MA, Soloway CT, Eldefrawy A, et al. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology 2011;77:588-91. [Crossref] [PubMed]
- O'Callaghan C, Dryden T, Hyatt A, et al. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option. Psychooncology 2014;23:1391-8. [Crossref] [PubMed]
- Mishra MV, Bennett M, Vincent A, et al. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications. PLoS One 2013;8:e68563. [Crossref] [PubMed]
- Loeb S, Folkvaljon Y, Curnyn C, et al. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden. JAMA Oncol 2017;3:1393-8. [Crossref] [PubMed]
- Liu J, Womble PR, Merdan S, et al. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer. Urology 2015;86:901-5. [Crossref] [PubMed]
- Filson CP, Schroeck FR, Ye Z, et al. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. J Urol 2014;192:75-80. [Crossref] [PubMed]
- Anandadas CN, Clarke NW, Davidson SE, et al. Early prostate cancer--which treatment do men prefer and why? BJU Int 2011;107:1762-8. [Crossref] [PubMed]
- Wilcox CB, Gilbourd D, Louie-Johnsun M. Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. BJU Int 2014;113 Suppl 2:64-8. [Crossref] [PubMed]
- Parker PA, Davis JW, Latini DM, et al. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU International 2016;117:469-77. [Crossref] [PubMed]
- UK CR. Prostate Cancer Statistics. Available online: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/
- Auffenberg GB, Lane BR, Linsell S, et al. Practice- vs physician-level variation in use of active surveillance for men with low-risk prostate cancer: Implications for collaborative quality improvement. JAMA Surg 2017;152:978-80. [Crossref] [PubMed]
- Weerakoon M, Papa N, Lawrentschuk N, et al. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry. BJU Int 2015;115 Suppl 5:50-6. [Crossref] [PubMed]
- Victorian Prostate Cancer Clinical Registry - Five year report. Available online: http://pcr.registry.org.au
- Louis AS, Kalnin R, Maganti M, et al. Oncologic outcomes following radical prostatectomy in the active surveillance era. Can Urol Assoc J 2013;7:E475-80. [Crossref] [PubMed]
- Huland H, Graefen M. Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment? Eur Urol 2015;68:175-8. [Crossref] [PubMed]
- Mitsuzuka K, Koga H, Sugimoto M, et al. Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan. Int J Urol 2015;22:754-9. [Crossref] [PubMed]
- Bruinsma SM, Roobol MJ, Carroll PR, et al. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer [mdash] results of a modified Delphi consensus procedure. Nat Rev Urol 2017;14:312-22. [Crossref] [PubMed]
- Bruinsma SM, Zhang L, Bangma CH, et al. Worldwide variation in determinants for inclusion and follow-up in active surveillance for low-risk prostate cancer: results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) initiative. J Urol 2017;97:e519. [Crossref]
- Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017;71:618-29. [Crossref] [PubMed]
- Schoots IG, Petrides N, Giganti F, et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol 2015;67:627-36. [Crossref] [PubMed]
- Moore CM, Giganti F, Albertsen P, et al. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. Eur Urol 2017;71:648-55. [Crossref] [PubMed]
- Korets R, Motamedinia P, Yeshchina O, et al. Accuracy of the Kattan nomogram across prostate cancer risk-groups. BJU International 2011;108:56-60. [Crossref] [PubMed]
- Shariat SF, Kattan MW, Vickers AJ, et al. Critical review of prostate cancer predictive tools. Future oncology 2009;5:1555-84. [Crossref] [PubMed]
- Mamawala MM, Rao K, Landis P, et al. Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance. BJU Int 2017;120:25-31. [Crossref] [PubMed]
- Venderbos LD, Roobol MJ, Bangma CH, et al. Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer. World J Urol 2016;34:253-60. [Crossref] [PubMed]
- Bruinsma SM, Zhang L, Roobol MJ, et al. The Movember Foundation's GAP3 cohort: A profile of the largest global prostate cancer active surveillance database to date. BJU Int 2017. [Epub ahead of print]. [PubMed]


text:
Review Detail
IndianPharma.co Featured
Recommended Pharmacies
Finally! A reputable online pharmacy
Searched the internet for days trying to find a pharmacy that wouldn't scam me or send me bad meds. This is the place to buy if you do not have a prescription and probably pretty good if you do. You can trust the meds and the reliability of the shipping in the time frame that they mention. Good luck!
Already have an account? Log in now


text:
Who we are
We are Tango Elegante, an Argentine Tango school run by Steve Gears. Our website address is: https://eleganttango.com. Steve Gears can be contacted as follows
What personal data we collect and why we collect it
User Profile
If you create a user account, for example by making a booking on a course, or leaving a comment on a post or article, we collect the following data; Name, email address, password (encrypted on our system – only you know what you use as a password), and personal account preferences chosen by you in setting up the user profile. This allows you to login to our website and use the tools available to view and manage your account. It also allows the Tango Elegante administrator (currently Steve Gears) to either manually or automatically administer your account where appropriate, for example when sending confirmation of booking emails, or notifications of purchase to Tango Elegante.
Purchase Details
When you make a purchase you will be required to create a user account (if not already created) and you are redirected to a payment system to complete the purchase using transactional data (name, email, date, item purchased, price etc) generated by Tango Elegante. The transactional data is stored by Tango Elegante for accounting purposes.
We do not store any financial data such as credit/debit card or bank details. These may be stored by our payment processor (currently Paypal. See Paypals Privacy Policy here ) and we may have access to transaction details stored by the payment processor in order to facilitate refunds, invoicing or similar transfers.
Purchase details may also be used to guide Tango Elegante to suggesting suitable follow-up purchases.
When you communicate to Tango Elegante via our email address, we use that information to respond appropriately, and where given permission to add your name and email details to our occasional newsletter list to keep you informed of events and classes and tango related information. Your contact details will also be stored in an offline email contacts address book and may be stored in a mobile device contact address book.
When you contact us via our phone number, we will use that information to respond appropriately either via phone call or text. Your phone number will be stored in the call/text log and the contact address book of the relevant mobile device.
Mobile devices
Tango Elegante uses mobile devices such as a smart phone or tablet as well as separate laptop computers to maintain contact with students and customers. The contact information collected in those device address books may be automatically uploaded to an online account facility such as Google Contacts as a backup to the damage or loss of the primary mobile device.
When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor's IP address and browser user agent string to help spam detection.
An 'anonymised' string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.
If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.
Contact forms
When you use our contact form we collect the data shown in the contact form and this is automatically emailed to us. We use this information to respond appropriately to you. We also ask you ( or you can use the Subject line 'Subscribe') if you wish to be added to our newsletter list, to keep you informed of events and classes and other useful tango related information.
If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year.
If you have an account and you log in to this site, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser.
When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select "Remember Me", your login will persist for two weeks. If you log out of your account, the login cookies will be removed.
If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.
Embedded content from other websites
Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website.
These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracing your interaction with the embedded content if you have an account and are logged in to that website.
We currently use two types of Analytics software;
Google Analytics (see Googles privacy policy here)
We use Google Analytics to monitor how visitors interact with our website so we can see where improvements are needed. We monitor click through from our paid advertising accounts to monitor how well our advertising is working for us. Most of this analysis is anonymous and data collected is aggregate except in the case where a purchase is made. In the case of a visitor making a purchase we may be able to track the purchasers use of the website from the point they click a paid advert link through to the point of purchase. This helps us to understand what attracts customers to making a purchase.
A WordPress plug-in called 'PrettyLink'
For certain types of advertising on third-party websites such as social media sites and dance directories, we use tracking links to allow us to count the number of visits via a specific advert to our website. This system logs the IP address of the visitor. We only look at aggregate data. We do not identify individuals.
If you see one of our links with a short URL such as 'https://eleganttango.com/pymca' (a link we have used on posters at our YMCA venue) you can still access our website by missing out the section of the URL after the last '/'. Your visit to our website will then not be logged by the PrettyLink module.
Social Linking
We embed Facebook Comments plugin to allow you to leave comment at our website using your Facebook account. This plugin may collect your IP address, your web browser User Agent, store and retrieve cookies on your browser, embed additional tracking, and monitor your interaction with the commenting interface, including correlating your Facebook account with whatever action you take within the interface (such as "liking" someone's comment, replying to other comments), if you are logged into Facebook. For more information about how this data may be used, please see Facebook's data privacy policy: https://www.facebook.com/about/privacy/update
We use GooglePlus Comments widget at our website for you to be able to comment at our web pages using your GooglePlus account. From this interaction Google automatically collects and store certain information in server logs like IP address, device event information such as crashes, system activity, hardware settings, browser type, browser language, the date and time of your request, in accordance with their data privacy policy: https://policies.google.com/privacy
We embed a Facebook widget to allow you to see number of likes/shares/recommends and "like/share/recommend" our web pages. This widget may collect your IP address, your web browser User Agent, store and retrieve cookies on your browser, embed additional tracking, and monitor your interaction with the widget, including correlating your Facebook account with whatever action you take within the widget (such as "liking/sharing/recommending" our webpage), if you are logged in to Facebook. For more information about how this data may be used, please see Facebook's data privacy policy: https://www.facebook.com/about/privacy/update
We use a Twitter Tweet widget at our website. As a result, our website makes requests to Twitter's servers for you to be able to tweet our webpages using your Twitter account. These requests make your IP address visible to Twitter, who may use it in accordance with their data privacy policy: https://twitter.com/en/privacy#update
We use a GooglePlus widget at our website. As a result, our website makes requests to Google's servers for you to be able to share our webpages using your GooglePlus account. These requests make your IP address visible to Google, who may use it in accordance with their data privacy policy: https://policies.google.com/privacy
We use a Linkedin Share widget at our website to allow you to share our webpages on Linkedin. These requests may track your IP address in accordance with their data privacy policy: https://www.linkedin.com/legal/privacy-policy
We use Reddit Badge widget at our website which may log information when you interact with the widget. This may include your IP address, user-agent string, browser type, operating system, referral URLs, device information (e.g., device IDs), pages visited, links clicked, user interactions (e.g., voting data), the requested URL and hardware settings, in accordance with their privacy policy: https://www.redditinc.com/policies/privacy-policy
We use StumbleUpon Badge widget at our website which may log information when you interact with the widget. Log Data is a form of Non-Identifying Information, in accordance with their privacy policy: http://www.stumbleupon.com/privacy
Who we share your data with
We do not share the data we collect from you with external organisations, except for transactional data needed for payment processing if you are purchasing something from us.
How long we retain your data
If you leave a comment, the comment and its meta-data are retained indefinitely. This is so we can recognise and approve any follow-up comments automatically instead of holding them in a moderation queue.
For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their user name). Website administrators can also see and edit that information.
For users that make a purchase on our website (if any), we store the transactional data relating to their purchases. Website administrators can see and edit that information.
What rights you have over your data
If you have a user account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. When making this request you will also separately receive details about any bookings and payments made through our website. Please note that payment details will not include data about refunds etc. This will be available via your Paypal or card processor account.
You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.
Where we send your data
Visitor comments may be checked through an automated spam detection service.
Contact information
If you wish to raise any concerns about this policy please contact Steve Gears at the email address at the head of this page.
How we protect your data
When you set up a user account you are asked to create a password. This password is encrypted before it is stored on our system, so no one but you can read it (including administrators of this site). It is recommended that you make this password a strong one, and if you feel it necessary, change this password on a regular basis.
We also operate an anti-spam system to keep spam out of our comment and form areas. This protects you from inadvertently responding to some fake or fraudulent spam message.
All comments are moderated meaning we review comments before allowing them to go live. If we feel comments which pass through our anti-spam system are inappropriate or offensive we delete them.
What data breach procedures we have in place
If we become aware of a breach in our data security, we will take an off-line backup of all user data, and then erase all user accounts, purchase data, and booking data from our system to prevent further unauthorised usage. We will then inform all users/customers affected of the potential breach and the data involved. Those individuals can then take action to protect themselves as they see fit, but as a minimum, if users/customers have used the same password on our system as elsewhere, we would recommend they change passwords on other critical websites they use.
What third parties we receive data from
We receive aggregate visitor data from third party platforms such as Google Adwords and Google Analytics. This is anonymous data, except in the case where a visitor has been tracked all the way to making a purchase (hence becoming a customer).
What automated decision making and/or profiling we do with user data
We do not use automated decision making or profiling.


text:
Do you have a ITNG fan in your life? Then why not take them along the the spectacular In The Night Garden Live? The delightful children's classic returns for its eighth consecutive summer tour, which also coincides with In the Night Garden's 10th anniversary celebrations.
I have been lucky enough to have been given some fantastic discount codes for all my lucky readers, valid until the 10th of march.
The dates are
Blackheath, London
25 May – 10 Jun 2017 (no shows Tue 30 May, 6 June)
Richmond Old Deer Park, London
17 Jun – 5 Jul 2017 (no shows Wed 21, 28 June)
Cannon Hill Park, Birmingham
12 Jul – 30 Jul 2017 (no shows Tue 18, 25 July)
intu Trafford Centre, Manchester
5 Aug – 28 Aug 2017 (no shows Tue 8, 15, 22 August)
You can order your tickets at http://www.nightgardenlive.com.
The code is EARLY77D. This unique code will provide you with £5 off orders over £60, or 5% off orders under that.
Best of all, all tickets are covered by the Flexible Exchange Policy, so if you need to you can swap your tickets for another time and date for a small fee.
Enjoy 🙂
*Coupon will take £5 off orders over £60, or 5% off orders under £60. Ts & Cs apply, please visit www.nightgardenlive.com/terms-and-conditions for more info.


text:
The New Yorker, May 30, 1953 P. 17
There is a drive under way to adapt home movies to television use. Apparently television has been eating up material of more or less professional origin greedily and amateur moviemakers are being urged to come to the rescue. Under the new scheme some reputations would be bound to suffer because of the foolishness of which normally rational people are capable in front of a home movie camera. We recall a home-movie in which we figured some years ago. The resurrection of it might prove embarrassing to one of the actors, then a frivolous young buck, now a corporation lawyer. In the picture he played a cow and permitted himself to be led out to graze by a Smith undergraduate, who played the ingenue. The American Bar Ass'n. could hardly condone this sort of performance. Our own role in the picture was that of the hero because we wrote the script.